Skip to content

Quadra R femoral stems 01.12.061Recalls & reported problems

Medacta International SA · Quadra R - Stem Cement-Less HAP 12/14 S. 1 · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07630030802393), received between Oct 12, 2017 and May 8, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Fracture” (1 report).

1 other recall cover devices cleared under the same FDA submission (K082792, K250450); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Fracture1

Patient problems

  • Implant Pain1
  • Loss of Range of Motion1
  • Unspecified Infection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 8, 2025Fracture; Fracture

    PATIENT UNDERWENT PRIMARY THA YEARS AGO. IN 2011 HAD TO UNDERGO REVISION SURGERY WHERE PRIMARY STEM WAS REPLACED BY SPACER. ON THE (B)(6) 2012 A 2ND REVISION SURGERY WAS PERFORMED. IMPLANTS USED FOR THIS REVISION ARE QUADRA-R SIZE 1, BIPOLAR HEAD SIZE 48, AND METAL FEMORAL HEAD SIZE L. ON THE (B)(6) 2019 3RD REVISION SURGERY WITH REVISION OF CUP, LINER AND HEAD. COMPETITOR COMPONENTS IMPLANTED, INCLUDING MERETE BIOBALL SIZE XL SLEEVE AND CERAMIC HEAD (OFF-LABEL) WHILE QUADRA-R STEM REMAINED IN PLACE. ON MONDAY, (B)(6) 2025 PATIENT CAME TO THE HOSPITAL BAD ISCHL WITH PAIN AND LACK OF MOBILITY IN HIS RIGHT HIP. XRAY WAS PERFORMED AND BROKEN NECK OF QUADRA-R WAS FOUND. REVISION PERFORMED ON (B)(6) 2025. STEM AND HEAD WERE REVISED TO COMPETITOR IMPLANTS.

    Patient problems: Implant Pain; Loss of Range of Motion

    MAUDE report 21984139 ↗
  • InjuryOct 12, 2017Adverse Event Without Identified Device or Use Problem

    REVISION SURGERY DUE TO INFECTION. THE SURGEON REPLACED THE MEDACTA STEM AND OTHER NON-MEDACTA COMPONENTS (CUP, HEAD AND LINER). THE SURGERY WAS COMPLETED SUCCESSFULLY. THE PATHOGEN WON'T BE AVAILABLE.

    Patient problems: Unspecified Infection

    MAUDE report 6944531 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K082792, K250450. One submission often covers many models, so check the product and lot details in each record.

  • Z-0791-2013 · Dec 17, 2012 · Terminated
    Medacta Quadra Trial Broach size 0 part # 01.10.10.045, for use with the Medacta Total Hip Prosthesis System. Product Usage - used to broach the intramedullary canal of the femur

Other Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented devices

All Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page